Experimental drug vorasidenib shows promise for treating glioma brain tumors

Tuesday, June 6, 2023 - 04:23 in Health & Medicine

The oral drug vorasidenib nearly tripled progression-free survival in patients with grade 2 gliomas compared to placebo, nearly 28 months versus 11 months, according to a recent study.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net